Cargando…

IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype

Bladder cancer is one of the most common malignancies of urinary tract. The current study aimed to investigate the role of insulin-like growth factor II messenger RNA binding protein 3 (IMP3) expression in the prognostic evaluation of non-muscle- invasive urothelial carcinoma of the bladder. Immunoh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Feiya, Zhou, Qiang, Meng, Lingquan, Xing, Nianzeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635297/ https://www.ncbi.nlm.nih.gov/pubmed/31277094 http://dx.doi.org/10.1097/MD.0000000000016009

Ejemplares similares

Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing
por: Wang, Fangming, et al.
Publicado: (2022)

Comparison of Radical Nephroureterectomy and Partial Ureterectomy for the Treatment of Upper Tract Urothelial Carcinoma
por: Zhang, Jianzhong, et al.
Publicado: (2018)

Increased H(2)S and its synthases in urothelial cell carcinoma of the bladder, and enhanced cisplatin-induced apoptosis following H(2)S inhibition in EJ cells
por: Wahafu, Wasilijiang, et al.
Publicado: (2018)

A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma
por: Feng, Yueyi, et al.
Publicado: (2019)

IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype
por: Kessler, S M, et al.
Publicado: (2015)

The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
por: Li, Wei Tse, et al.
Publicado: (2021)

The Clinical Impact of Tumor Grade Heterogeneity in Non-muscle-invasive Urothelial Carcinoma of the Bladder
por: CULPAN, Meftun, et al.
Publicado: (2021)

Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF‐κB, MAPKs, and Nrf2 signaling pathways in rats
por: Zhao, Qinxin, et al.
Publicado: (2020)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma
por: Basatac, Cem, et al.
Publicado: (2019)

Bioinformatic Identification of Potential Hub Genes in Muscle-Invasive Bladder Urothelial Carcinoma
por: Guo, Changgang, et al.
Publicado: (2020)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Muscle invasive urinary bladder urothelial carcinoma presenting with secondary nephrotic symptoms
por: Mizusawa, Hiroya, et al.
Publicado: (2021)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

PD-L1 Expression in Muscle-Invasive Urinary Bladder Urothelial Carcinoma According to Basal/Squamous-Like Phenotype
por: Kim, Bohyun, et al.
Publicado: (2020)

Moderate or severe LUTS is associated with increased recurrence of non - muscle - invasive urothelial carcinoma of the bladder
por: Lunney, Austin, et al.
Publicado: (2019)

Gastrocnemius acrometastasis from muscle-invasive urothelial bladder carcinoma: A case report
por: Roslly, Mohd Zulkimi, et al.
Publicado: (2021)

Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans
por: Tsamouri, Maria Malvina, et al.
Publicado: (2021)

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Kim, Hongsik, et al.
Publicado: (2023)

Young age increases the risk of lymph-node metastasis in patients with muscle-invasive bladder urothelial carcinoma
por: Tian, Zijian, et al.
Publicado: (2020)

Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the Bladder
por: Itami, Yoshitaka, et al.
Publicado: (2020)

Expression of Fibroblast Growth Factor Receptor 3 in the Recurrence of Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Maeng, Young-Hee, et al.
Publicado: (2010)

Upregulation of Twist2 in Non-Muscle Invasive Urothelial Carcinoma of the Bladder Correlate with Response to Treatment and Progression
por: Wishahi, Mohamed, et al.
Publicado: (2018)

The Landscape of Long Non-Coding RNA Dysregulation and Clinical Relevance in Muscle Invasive Bladder Urothelial Carcinoma
por: Shen, Haotian, et al.
Publicado: (2019)

Mycotic Abdominal Aortic Aneurysm Secondary to BCG Therapy for Non-muscle Invasive Urothelial Carcinoma of the Bladder
por: Godard, Levi, et al.
Publicado: (2023)

Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2017)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
por: Sung, Hyun Hwan, et al.
Publicado: (2022)

LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway
por: Jiang, Tao, et al.
Publicado: (2020)

Osteoclast-type giant cell carcinoma of the urinary bladder: An unusual and aggressive variant of urothelial carcinoma
por: Osman, Can, et al.
Publicado: (2018)

Transcriptome Profiling of a Multiple Recurrent Muscle-Invasive Urothelial Carcinoma of the Bladder by Deep Sequencing
por: Zhang, Shufang, et al.
Publicado: (2014)

Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder
por: Massari, Francesco, et al.
Publicado: (2015)

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2022)

Urinary laminin‐γ2 is a novel biomarker of non‐muscle invasive urothelial carcinoma
por: Kamada, Masayuki, et al.
Publicado: (2015)

Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells
por: Gai, Jun-Wei, et al.
Publicado: (2018)

Circular RNA circHIPK3 promotes cell proliferation and invasion of prostate cancer by sponging miR-193a-3p and regulating MCL1 expression
por: Chen, Dong, et al.
Publicado: (2019)

Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
por: Sanford, Thomas, et al.
Publicado: (2018)

Plasmacytoid urothelial carcinoma of the bladder with extensive scrotal wall invasion
por: Wang, Yong Gang, et al.
Publicado: (2016)

Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
por: Frydenlund, Noah, et al.
Publicado: (2018)

Preoperative Platelet Count Correlates With Postoperative Perineural Invasion on Specimen in Patients Treated With Radical Prostatectomy
por: Wang, Fangming, et al.
Publicado: (2022)

Status of Her2 over expression in muscle invasive urothelial bladder carcinoma: Report of 21 cases
por: Mejri, Nesrine, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s63062du96co1ptt2q5lka0mg8